FDA labeling for EGRIFTA WR identifies tesamorelin as a therapy for reducing excess abdominal fat in adults with HIV-associated lipodystrophy and states that it is not indicated for weight-loss management
Answer: Yes, it brightens and evens skin tone gradually by reducing melanin production with consistent use
Common CVS Caremark Denial Reasons "Not on formulary" Standard denial since July 2025 "Step therapy not completed" Haven't tried Wegovy first "Does not meet criteria" BMI or comorbidity requirements not documented "Insufficient documentation" Missing Wegovy trial records What to Do: Get the Denial in Writing Request a written denial letter with the specific reason for denial
Focus on one meaningful action each day, taking your supplements, eating a proper meal, or getting to bed on time
All pregnant people, regardless of insurance status, are encouraged to establish care with an OB-GYN, certified nurse midwife, or family physician
Contact your GP, midwife or health visitor if you are struggling with postpartum weight concerns and considering weight loss medications